Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · Real-Time Price · USD

1.120

+0.030 (2.75%)

At close: Jul 15, 2026, 4:00 PM EDT

1.150

+0.030 (2.68%)

Pre-market: Jul 16, 2026, 6:00 AM EDT

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.19	45.45	71.19	63.23	33.69	51.67
Short-Term Investments	148.7	145.5	284.54	431.01	297.5	148.93
Cash & Short-Term Investments	170.89	190.94	355.72	494.25	331.19	200.6
Cash Growth	-44.09%	-46.32%	-28.03%	49.23%	65.10%	-27.56%
Accounts Receivable	-	-	-	-	1.98	2
Other Receivables	-	-	-	-	0.08	0.08
Total Trade Receivables	-	-	-	-	2.07	2.08
Other Current Assets	4.04	5.5	6.54	11.26	7.06	6.76
Total Current Assets	174.93	196.45	362.26	505.5	340.31	209.44
Net Property, Plant & Equipment	25.8	26.91	32.77	4.78	9.91	10.94
Other Long-Term Assets	1.87	1.87	1.92	1.87	0.39	0.84
Total Assets	202.6	225.23	396.95	512.15	350.61	221.22
Accounts Payable	0.36	0.48	5.96	4.53	1.58	2.97
Accrued Expenses	8.28	14.44	26.72	22.68	19.88	11.99
Current Portion of Leases	1.71	1.45	0.54	1.32	2.46	1.87
Total Current Liabilities	10.36	16.37	33.22	28.52	23.91	16.83
Long-Term Debt	-	-	30.21	10.05	9.93	-
Long-Term Leases	27.07	27.66	29.44	-	3.43	5.33
Total Long-Term Liabilities	27.07	27.66	59.65	10.05	13.36	5.33
Total Liabilities	37.43	44.02	92.87	38.58	37.27	22.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,045	1,041	1,014	972.97	653.71	414.35
Accumulated Other Comprehensive Income	-0.34	-0.02	0.32	0.35	-1.96	-0.2
Retained Earnings	-879.44	-859.4	-710.05	-499.75	-338.41	-215.09
Shareholders' Equity	165.17	181.21	304.08	473.58	313.34	199.06
Total Liabilities & Equity	202.6	225.23	396.95	512.15	350.61	221.22
Total Debt	28.78	29.11	60.19	11.37	15.82	7.19
Net Cash (Debt)	142.11	161.84	295.53	482.87	315.37	193.4
Net Cash Growth	-12.19%	-45.24%	-38.80%	53.11%	63.07%	-30.15%
Net Cash Per Share	2.31	2.64	4.88	8.22	7.51	5.39
Book Value	165.17	181.21	304.08	473.58	313.34	199.06
Book Value Per Share	2.69	2.95	5.02	8.07	7.46	5.55
Tangible Book Value	165.17	181.21	304.08	473.58	313.34	199.06
Tangible Book Value Per Share	2.69	2.95	5.02	8.07	7.46	5.55

SEC Filings: 10-K · 10-Q